Therefore, the objective of this review is to characterize the studies of BCR-ABL1-negative chronic myeloproliferative neoplasms and to compare the frequency of JAK2, MPL and CALR mutations in PV, ET and PMF. This evidence concerns the gene MPL and essential thrombocythemia.